Cancer Res Treat.
2015 Oct;47(4):897-903. 10.4143/crt.2014.135.
Long-term Outcome of Chondrosarcoma: A Single Institutional Experience
- Affiliations
-
- 1Department of Orthopaedic Surgery, Seoul National University Hospital, Seoul, Korea. hik19@snu.ac.kr
- KMID: 2403410
- DOI: http://doi.org/10.4143/crt.2014.135
Abstract
- PURPOSE
The prognostic factors of chondrosarcoma remain uncertain as only a few large studies with long-term follow-up have been reported. The aim of this study was to analyze oncological outcomes and prognostic factors.
MATERIALS AND METHODS
A retrospective review of oncological outcomes and prognostic factors was performed on 125 consecutive chondrosarcoma patients who underwent surgery at our institution.
RESULTS
Overall survival was 91.6%+/-2.5%, 84.1%+/-3.8%, and 84.1%+/-3.8% at 5, 10, and 15 years respectively. Among the histological types, dedifferentiated type showed the worst survival (p < 0.001). As for conventional type chondrosarcoma, histologic grade and anatomical location predicted outcome, with high-grade with axial location having the worst outcome (p < 0.001). In contrast, low-grade chondrosarcoma of appendicular skeleton could be treated safely by intralesional curettage.
CONCLUSION
Histological type was significantly associated with the outcome of chondrosarcoma. For the conventional type, histologic grade and anatomical location predicted outcome, with high-grade with axial location having the worst outcome.
